User contributions for JD Hardman
Results for JD Hardman talk block log uploads logs global block log global account filter log
A user with 40 edits. Account created on 7 August 2024.
12 November 2024
- 23:3923:39, 12 November 2024 diff hist +29 N Talk:XBiotech ←Created page with '{{WikiProject United States}}'
- 23:3923:39, 12 November 2024 diff hist −23 XBiotech →References
- 23:3823:38, 12 November 2024 diff hist +69 N Draft:XBiotech JD Hardman moved page Draft:XBiotech to XBiotech: done the work current Tag: New redirect
- 23:3823:38, 12 November 2024 diff hist 0 m XBiotech JD Hardman moved page Draft:XBiotech to XBiotech: done the work
4 October 2024
- 18:0818:08, 4 October 2024 diff hist 0 N User talk:JD Hardman ←Created blank page current
- 18:0818:08, 4 October 2024 diff hist 0 N User:JD Hardman ←Created blank page current
- 18:0718:07, 4 October 2024 diff hist +8 Vilhelm Magnus →Biography
- 18:0718:07, 4 October 2024 diff hist +153 Vilhelm Magnus No edit summary
- 18:0618:06, 4 October 2024 diff hist +3 Vilhelm Magnus →References
- 18:0618:06, 4 October 2024 diff hist +140 Vilhelm Magnus No edit summary
- 18:0518:05, 4 October 2024 diff hist +75 N User:JD Hardman/sandbox JD Hardman moved page User:JD Hardman/sandbox to Vilhelm Magnus current Tag: New redirect
- 18:0518:05, 4 October 2024 diff hist +4 Vilhelm Magnus →Biography
- 18:0418:04, 4 October 2024 diff hist +269 Vilhelm Magnus →Biography
- 18:0118:01, 4 October 2024 diff hist +4 Vilhelm Magnus →Biography
- 18:0018:00, 4 October 2024 diff hist +8 Vilhelm Magnus →Biography
- 18:0018:00, 4 October 2024 diff hist +8 Vilhelm Magnus →Biography
- 17:5917:59, 4 October 2024 diff hist +59 Vilhelm Magnus →Biography
- 17:5917:59, 4 October 2024 diff hist +301 Vilhelm Magnus No edit summary
- 17:5717:57, 4 October 2024 diff hist −12 Vilhelm Magnus No edit summary
- 17:5617:56, 4 October 2024 diff hist +743 N Vilhelm Magnus ←Created page with '{{User sandbox}} <!-- EDIT BELOW THIS LINE --> Vilhelm Magnus (1871–1929) was a Norwegian neurosurgeon born in Fillmore County, Minnesota, United States. After graduating in Oslo, he began clinical training in neurology and was among a group of neurologists dissatisfied with the prevailing therapeutic nihilism toward nervous system diseases. Influenced by Victor Horsley, Magnus focused on surgically treatable neurological conditions and worked over 25 ye...'
- 16:1716:17, 4 October 2024 diff hist −1 XBiotech No edit summary
- 16:1616:16, 4 October 2024 diff hist +16 XBiotech No edit summary
- 16:1516:15, 4 October 2024 diff hist +106 XBiotech →Xilonix
- 16:1316:13, 4 October 2024 diff hist +30 XBiotech No edit summary
- 16:1216:12, 4 October 2024 diff hist +36 XBiotech No edit summary
7 August 2024
- 15:5415:54, 7 August 2024 diff hist +210 XBiotech No edit summary
- 15:2415:24, 7 August 2024 diff hist −314 XBiotech No edit summary
- 15:2115:21, 7 August 2024 diff hist +132 XBiotech →References
- 15:2015:20, 7 August 2024 diff hist +32 XBiotech No edit summary
- 15:1815:18, 7 August 2024 diff hist +4 XBiotech →References
- 15:1815:18, 7 August 2024 diff hist 0 XBiotech →References
- 15:1715:17, 7 August 2024 diff hist +1 XBiotech No edit summary
- 15:1615:16, 7 August 2024 diff hist +659 XBiotech No edit summary
- 15:1315:13, 7 August 2024 diff hist +64 XBiotech →Xilonix
- 15:1015:10, 7 August 2024 diff hist +1,308 XBiotech →History
- 15:0815:08, 7 August 2024 diff hist −26 XBiotech No edit summary
- 15:0715:07, 7 August 2024 diff hist +21 XBiotech →History
- 15:0415:04, 7 August 2024 diff hist +1,002 XBiotech No edit summary
- 15:0115:01, 7 August 2024 diff hist +2,977 N XBiotech ←Created page with 'XBiotech Inc. is an American clinical-stage biopharmaceutical company based in Austin, Texas. It specializes in the research and development of monoclonal antibodies for the treatment of diseases such as cancer, diabetes, inflammatory skin disease, and vascular disease. ==History== XBiotech was founded in 2005 in Canada by John Simard to develop cancer vaccines. The company moved its headquarters to Austin, Texas in 2008. In September 2016, XBiotech was...'
